Flecainide for recurrent malignant ventricular arrhythmias in two siblings with Andersen-Tawil syndrome

Heart Rhythm. 2007 Apr;4(4):508-11. doi: 10.1016/j.hrthm.2006.12.031. Epub 2006 Dec 28.

Authors

Regina Bökenkamp¹, Arthur A Wilde, Martin J Schalij, Nico A Blom

Affiliation

¹ Leiden University Medical Center, Leiden, The Netherlands. r.bokenkamp.kjc@lumc.nl <r.bokenkamp.kjc@lumc.nl>

PMID: 17399642
DOI: 10.1016/j.hrthm.2006.12.031

No abstract available

Publication types

Case Reports

MeSH terms

Andersen Syndrome / complications
Andersen Syndrome / drug therapy*
Andersen Syndrome / genetics
Andersen Syndrome / therapy
Anti-Arrhythmia Agents / therapeutic use*
Child
Child, Preschool
Defibrillators, Implantable
Female
Flecainide / therapeutic use*
Genetic Predisposition to Disease
Humans
Male
Mutation / genetics
Potassium Channels, Inwardly Rectifying / genetics
Recurrence
Siblings
Tachycardia, Ventricular / drug therapy*
Tachycardia, Ventricular / etiology
Tachycardia, Ventricular / therapy
Ventricular Premature Complexes / etiology
Ventricular Premature Complexes / therapy

Substances

Anti-Arrhythmia Agents
KCNJ2 protein, human
Potassium Channels, Inwardly Rectifying
Flecainide